1. Home
  2. RSKD vs ENGN Comparison

RSKD vs ENGN Comparison

Compare RSKD & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riskified Ltd.

RSKD

Riskified Ltd.

HOLD

Current Price

$4.52

Market Cap

755.1M

Sector

Technology

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$11.12

Market Cap

605.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RSKD
ENGN
Founded
2012
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
755.1M
605.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
RSKD
ENGN
Price
$4.52
$11.12
Analyst Decision
Buy
Buy
Analyst Count
8
7
Target Price
$5.91
$22.71
AVG Volume (30 Days)
463.0K
399.8K
Earning Date
03-04-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$338,838,000.00
N/A
Revenue This Year
$6.65
N/A
Revenue Next Year
$9.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.54
N/A
52 Week Low
$3.94
$2.65
52 Week High
$6.00
$12.25

Technical Indicators

Market Signals
Indicator
RSKD
ENGN
Relative Strength Index (RSI) 37.00 64.90
Support Level $4.51 $8.68
Resistance Level $4.64 $12.25
Average True Range (ATR) 0.12 0.83
MACD -0.03 0.27
Stochastic Oscillator 11.57 72.42

Price Performance

Historical Comparison
RSKD
ENGN

About RSKD Riskified Ltd.

Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: